| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Financial Officer | Chief Financial Officer
1 company
Stelzer Laurie is a SVP, Chief Financial Officer at HALOZYME THERAPEUTICS, INC.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $8.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2015 | HALO Halozyme Therapeutics, Inc. | Chief Financial Officer | Buy | 10,000 | $17.24 | $172,384.00 | New |